|
CTSO Cytosorbents Corp 1175151 |
| Balance Sheet |
|
Current Assets
|
$17,757,000.00 |
|
Assets
|
$40,562,000.00 |
|
Current Liabilities
|
$16,303,000.00 |
|
Liabilities
|
$38,368,000.00 |
|
Equity
|
$2,194,000.00 |
|
Shares Out
|
62733305.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,162,000.00 |
|
Investing Cash Flow
|
$-46,000.00 |
| Market Analysis |
Market Cap
|
$21,956,656.75 |
|
Price
|
$0.36 |
|
BVPS
|
0.04 |
|
PB
|
8.75 |
|
EPS
|
-0.08 |
|
PS
|
0.69 |
|
FCF
|
$-1,173,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:41 |
|
| Apr |
May |
Jun |
| 2026-03-25 |
-0.07 |
|
|
2026-05-13 |
-0.05 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.05 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.04 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CTSO documents filed with the SEC.
CTSO Filings
Clear
